OOIR: Observatory of International Research

Papers

(The TQCC of Heart Failure Clinics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Unusual Forms of Pulmonary Hypertension	26
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	23
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	22
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy	21
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias	20
When all Else Fails, Try This	20
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	18
Forthcoming Issues	17
Changing Landscape of Heart Failure Imaging	15
Therapy-Related Clonal Hematopoiesis	14
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	14
Genetics of High-Altitude Pulmonary Edema	13
Preload Reduction Therapies in Heart Failure	13
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications	13
Contributors	12
Mitral Regurgitation	12
Contributors	12
Arrhythmias in Adult Congenital Heart Disease Heart Failure	12
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	12
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction	11
Contributors	10
Copyright	10
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure	10
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	10
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	9

Heart Failure Clinics	9
Coronary Angiography in the Evaluation of Systolic Heart Failure	9
What Is New in Risk Assessment in Nuclear Cardiology?	9
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	9
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	8
Hypertrophic Cardiomyopathy	8
Contributors	8
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	7
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	7
Guide to Temporary Mechanical Support in Cardiogenic Shock	7
Arrythmia-Mediated Valvular Heart Disease	7
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	7
Myocardial Dysfunction in Patients with Cancer	7
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	6
Preface	6
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	6
Cardiac Contractility Modulation	6
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	6
Cardiac Amyloidosis	6
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	6
Noncoding RNAs in Pulmonary Arterial Hypertension	6
Epigenetics of Heart Failure	6
Shifting the Epigenetic and Multi-Omic Frontier to Get the Heart in Top Gear	6
SGLT2 Inhibitors in Heart Failure	6
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	5
Contributors	5
Contents	5
Copyright	5
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	5
Contents	5
Contents	4
Contents	4
Copyright	4
Contents	4
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	4
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	4
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	4
Aortic Valvular Stenosis and Heart Failure	4
Evolving Strategies in Cardiac Amyloidosis	4
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	4
Adults with Congenital Heart Disease and Transplant	4
Contents	4
SGLT2 Inhibitors and Peripheral Vascular Events	3
Novel Non-pharmacological Approaches to Heart Failure	3
Contributors	3
Exercise Testing in Pulmonary Hypertension and Heart Failure	3
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	3
Risk Factors for Progression in Hypertrophic Cardiomyopathy	3
Forthcoming Issues	3
Clinical Use of Biomarkers in Cardiac Amyloidosis	3

Clinical Practice Guidelines in Cardio-Oncology	3
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	3
Pathophysiology of Cardiac Amyloidosis	3
Remote Monitoring Devices and Heart Failure	3